These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17605649)

  • 1. New antiarrhythmic treatment of atrial fibrillation.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):707-14. PubMed ID: 17605649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
    Conway E; Musco S; Kowey PR
    Am J Cardiol; 2008 Sep; 102(6A):12H-19H. PubMed ID: 18790110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New antiarrhythmic drugs for treatment of atrial fibrillation].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2010; 126(19):2255-62. PubMed ID: 21086684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
    Krishnamoorthy S; Lip GY
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1191-6. PubMed ID: 19604120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches for pharmacological management of atrial fibrillation.
    Ehrlich JR; Nattel S
    Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
    Camm AJ; Savelieva I
    J Interv Card Electrophysiol; 2008 Oct; 23(1):7-14. PubMed ID: 18523740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer antiarrhythmic drugs.
    Gupta AK; Maheshwari A; Thakur RK; Lokhandwala YY
    Indian Heart J; 2001; 53(3):354-60. PubMed ID: 11516042
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of drug therapy for sustained ventricular tachyarrhythmias.
    Mitchell LB
    Cardiol Clin; 2008 Aug; 26(3):405-18, vi. PubMed ID: 18538187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantiarrhythmic drug therapy for atrial fibrillation.
    Murray KT; Mace LC; Yang Z
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S88-90. PubMed ID: 17336893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiadrenergic therapy in the control of atrial fibrillation.
    Naccarelli GV
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S33-43. PubMed ID: 15965571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiarrhythmic drugs for the treatment of atrial fibrillation.
    Castro A; Bianconi L; Santini M
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):249-59. PubMed ID: 11916001
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S27-31. PubMed ID: 12746749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
    Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
    Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.